Lord Keen of Elie Alert Sample


Alert Sample

View the Parallel Parliament page for Lord Keen of Elie

Information between 8th July 2025 - 26th September 2025

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Division Votes
9 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 251 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 284 Noes - 239
9 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and against the House
One of 134 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 139 Noes - 158
9 Jul 2025 - House of Lords (Hereditary Peers) Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 246 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 265 Noes - 247
15 Jul 2025 - Renters’ Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and against the House
One of 191 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 215 Noes - 240
15 Jul 2025 - Renters’ Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 171 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 282 Noes - 158
15 Jul 2025 - Renters’ Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 188 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 237 Noes - 223
15 Jul 2025 - Renters’ Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and against the House
One of 73 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 106 Noes - 148
15 Jul 2025 - Renters’ Rights Bill - View Vote Context
Lord Keen of Elie voted No - in line with the party majority and against the House
One of 142 Conservative No votes vs 0 Conservative Aye votes
Tally: Ayes - 214 Noes - 153
14 Jul 2025 - Employment Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 173 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 267 Noes - 153
14 Jul 2025 - Employment Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 171 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 264 Noes - 158
22 Jul 2025 - Enterprise Act 2002 (Mergers Involving Newspaper Enterprises and Foreign Powers) Regulations 2025 - View Vote Context
Lord Keen of Elie voted No - in line with the party majority and in line with the House
One of 100 Conservative No votes vs 41 Conservative Aye votes
Tally: Ayes - 155 Noes - 267
23 Jul 2025 - Employment Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 181 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 290 Noes - 143
23 Jul 2025 - Employment Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and in line with the House
One of 173 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 271 Noes - 138
23 Jul 2025 - Employment Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and against the House
One of 148 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 171 Noes - 189
23 Jul 2025 - Employment Rights Bill - View Vote Context
Lord Keen of Elie voted Aye - in line with the party majority and against the House
One of 171 Conservative Aye votes vs 0 Conservative No votes
Tally: Ayes - 198 Noes - 198


Speeches
Lord Keen of Elie speeches from: Renters’ Rights Bill
Lord Keen of Elie contributed 8 speeches (1,458 words)
Tuesday 15th July 2025 - Lords Chamber
Ministry of Housing, Communities and Local Government
Lord Keen of Elie speeches from: Trial by Jury: Proposed Restrictions
Lord Keen of Elie contributed 1 speech (76 words)
Monday 14th July 2025 - Lords Chamber
Ministry of Justice
Lord Keen of Elie speeches from: Housing: National Tenant Body
Lord Keen of Elie contributed 1 speech (91 words)
Thursday 10th July 2025 - Lords Chamber
Ministry of Housing, Communities and Local Government
Lord Keen of Elie speeches from: Prisons: Early Release
Lord Keen of Elie contributed 1 speech (69 words)
Wednesday 9th July 2025 - Lords Chamber
Ministry of Justice
Lord Keen of Elie speeches from: House of Lords (Hereditary Peers) Bill
Lord Keen of Elie contributed 1 speech (365 words)
Report stage part one
Wednesday 9th July 2025 - Lords Chamber
Leader of the House


Written Answers
Sexual Offences: Medical Treatments
Asked by: Lord Keen of Elie (Conservative - Life peer)
Tuesday 23rd September 2025

Question to the Ministry of Justice:

To ask His Majesty's Government what preparations they have made to make chemical castration mandatory for certain serious sexual offenders, and by what date will the policy be introduced.

Answered by Lord Timpson - Minister of State (Ministry of Justice)

As part of the Government’s efforts to crackdown on sex crimes, the Government has committed to extending Medication to Manage Problematic Sexual Arousal (MMPSA) to twenty prisons, ramped up from the current four in the South West.

MMPSA is a pharmaceutical intervention prescribed by clinicians to individuals, based on clinical need; medication can be given in the form of testosterone suppressing medication known as anti-androgens and selective serotonin reuptake inhibitiors (SSRIs). There is evidence of serious medium and longer-term side effects and risks associated with taking anti-androgens, which need to be carefully monitored by clinicians whilst a patient is taking them.

MMPSA is most effective when used alongside psychological interventions which includes accredited offending behaviour programmes, coordinated support such as therapy and probation supervision. This integrated approach ensures that public safety is prioritised.

The evidence of outcomes related to a reduction in psychological distress is building. To strengthen our evidence base, the Government is going further than the Independent Sentencing Review recommendation by committing to extending and expanding the existing MMPSA feasibility pilot beyond the South-West region, to two additional regions, the North East and the North West, as the first steps towards a national roll-out. We are continuing to work closely with our partners across health and justice agencies to inform our plans for implementation throughout the Autumn.

Alongside the expansion of the pilot, we are working closely with experts to ensure all future decisions are based on strong evidence which prioritises public safety, including through our collaboration with Nottingham Trent University to conduct a Randomised Controlled Trial to understand the effectiveness of SSRIs in managing problematic sexual behaviours.

We are also conducting international research to inform our approach to MMPSA. This has included hosting an expert roundtable with international representation from Sweden and Germany, and targeted engagement with countries who use this medication, as recommended in the Review. A summary of the evidence available will be deposited in the House Library.

As the evidence builds, it is right we consider ways we can increase the use of MMPSA and we will continue to explore whether we might mandate this treatment in future.

Sexual Offences: Medical Treatments
Asked by: Lord Keen of Elie (Conservative - Life peer)
Tuesday 23rd September 2025

Question to the Ministry of Justice:

To ask His Majesty's Government what progress they have made in assessing the risks and benefits of chemical castration for sex offenders.

Answered by Lord Timpson - Minister of State (Ministry of Justice)

As part of the Government’s efforts to crackdown on sex crimes, the Government has committed to extending Medication to Manage Problematic Sexual Arousal (MMPSA) to twenty prisons, ramped up from the current four in the South West.

MMPSA is a pharmaceutical intervention prescribed by clinicians to individuals, based on clinical need; medication can be given in the form of testosterone suppressing medication known as anti-androgens and selective serotonin reuptake inhibitiors (SSRIs). There is evidence of serious medium and longer-term side effects and risks associated with taking anti-androgens, which need to be carefully monitored by clinicians whilst a patient is taking them.

MMPSA is most effective when used alongside psychological interventions which includes accredited offending behaviour programmes, coordinated support such as therapy and probation supervision. This integrated approach ensures that public safety is prioritised.

The evidence of outcomes related to a reduction in psychological distress is building. To strengthen our evidence base, the Government is going further than the Independent Sentencing Review recommendation by committing to extending and expanding the existing MMPSA feasibility pilot beyond the South-West region, to two additional regions, the North East and the North West, as the first steps towards a national roll-out. We are continuing to work closely with our partners across health and justice agencies to inform our plans for implementation throughout the Autumn.

Alongside the expansion of the pilot, we are working closely with experts to ensure all future decisions are based on strong evidence which prioritises public safety, including through our collaboration with Nottingham Trent University to conduct a Randomised Controlled Trial to understand the effectiveness of SSRIs in managing problematic sexual behaviours.

We are also conducting international research to inform our approach to MMPSA. This has included hosting an expert roundtable with international representation from Sweden and Germany, and targeted engagement with countries who use this medication, as recommended in the Review. A summary of the evidence available will be deposited in the House Library.

As the evidence builds, it is right we consider ways we can increase the use of MMPSA and we will continue to explore whether we might mandate this treatment in future.

Sexual Offences: Medical Treatments
Asked by: Lord Keen of Elie (Conservative - Life peer)
Tuesday 23rd September 2025

Question to the Ministry of Justice:

To ask His Majesty's Government what possible risk factors they have identified in the implementation of chemical castration for sex offenders, and what plans they have to mitigate against these risks when implementing the policy.

Answered by Lord Timpson - Minister of State (Ministry of Justice)

As part of the Government’s efforts to crackdown on sex crimes, the Government has committed to extending Medication to Manage Problematic Sexual Arousal (MMPSA) to twenty prisons, ramped up from the current four in the South West.

MMPSA is a pharmaceutical intervention prescribed by clinicians to individuals, based on clinical need; medication can be given in the form of testosterone suppressing medication known as anti-androgens and selective serotonin reuptake inhibitiors (SSRIs). There is evidence of serious medium and longer-term side effects and risks associated with taking anti-androgens, which need to be carefully monitored by clinicians whilst a patient is taking them.

MMPSA is most effective when used alongside psychological interventions which includes accredited offending behaviour programmes, coordinated support such as therapy and probation supervision. This integrated approach ensures that public safety is prioritised.

The evidence of outcomes related to a reduction in psychological distress is building. To strengthen our evidence base, the Government is going further than the Independent Sentencing Review recommendation by committing to extending and expanding the existing MMPSA feasibility pilot beyond the South-West region, to two additional regions, the North East and the North West, as the first steps towards a national roll-out. We are continuing to work closely with our partners across health and justice agencies to inform our plans for implementation throughout the Autumn.

Alongside the expansion of the pilot, we are working closely with experts to ensure all future decisions are based on strong evidence which prioritises public safety, including through our collaboration with Nottingham Trent University to conduct a Randomised Controlled Trial to understand the effectiveness of SSRIs in managing problematic sexual behaviours.

We are also conducting international research to inform our approach to MMPSA. This has included hosting an expert roundtable with international representation from Sweden and Germany, and targeted engagement with countries who use this medication, as recommended in the Review. A summary of the evidence available will be deposited in the House Library.

As the evidence builds, it is right we consider ways we can increase the use of MMPSA and we will continue to explore whether we might mandate this treatment in future.

Sexual Offences: Medical Treatments
Asked by: Lord Keen of Elie (Conservative - Life peer)
Tuesday 23rd September 2025

Question to the Ministry of Justice:

To ask His Majesty's Government what progress they have made regarding their pilot for the voluntary chemical castration of sex offenders, and whether they will provide a timeline for its implementation.

Answered by Lord Timpson - Minister of State (Ministry of Justice)

As part of the Government’s efforts to crackdown on sex crimes, the Government has committed to extending Medication to Manage Problematic Sexual Arousal (MMPSA) to twenty prisons, ramped up from the current four in the South West.

MMPSA is a pharmaceutical intervention prescribed by clinicians to individuals, based on clinical need; medication can be given in the form of testosterone suppressing medication known as anti-androgens and selective serotonin reuptake inhibitiors (SSRIs). There is evidence of serious medium and longer-term side effects and risks associated with taking anti-androgens, which need to be carefully monitored by clinicians whilst a patient is taking them.

MMPSA is most effective when used alongside psychological interventions which includes accredited offending behaviour programmes, coordinated support such as therapy and probation supervision. This integrated approach ensures that public safety is prioritised.

The evidence of outcomes related to a reduction in psychological distress is building. To strengthen our evidence base, the Government is going further than the Independent Sentencing Review recommendation by committing to extending and expanding the existing MMPSA feasibility pilot beyond the South-West region, to two additional regions, the North East and the North West, as the first steps towards a national roll-out. We are continuing to work closely with our partners across health and justice agencies to inform our plans for implementation throughout the Autumn.

Alongside the expansion of the pilot, we are working closely with experts to ensure all future decisions are based on strong evidence which prioritises public safety, including through our collaboration with Nottingham Trent University to conduct a Randomised Controlled Trial to understand the effectiveness of SSRIs in managing problematic sexual behaviours.

We are also conducting international research to inform our approach to MMPSA. This has included hosting an expert roundtable with international representation from Sweden and Germany, and targeted engagement with countries who use this medication, as recommended in the Review. A summary of the evidence available will be deposited in the House Library.

As the evidence builds, it is right we consider ways we can increase the use of MMPSA and we will continue to explore whether we might mandate this treatment in future.

Sexual Offences: Medical Treatments
Asked by: Lord Keen of Elie (Conservative - Life peer)
Tuesday 23rd September 2025

Question to the Ministry of Justice:

To ask His Majesty's Government what research they have conducted into countries which have a policy of chemical castration for sex offenders ahead of the proposed trial in the United Kingdom.

Answered by Lord Timpson - Minister of State (Ministry of Justice)

As part of the Government’s efforts to crackdown on sex crimes, the Government has committed to extending Medication to Manage Problematic Sexual Arousal (MMPSA) to twenty prisons, ramped up from the current four in the South West.

MMPSA is a pharmaceutical intervention prescribed by clinicians to individuals, based on clinical need; medication can be given in the form of testosterone suppressing medication known as anti-androgens and selective serotonin reuptake inhibitiors (SSRIs). There is evidence of serious medium and longer-term side effects and risks associated with taking anti-androgens, which need to be carefully monitored by clinicians whilst a patient is taking them.

MMPSA is most effective when used alongside psychological interventions which includes accredited offending behaviour programmes, coordinated support such as therapy and probation supervision. This integrated approach ensures that public safety is prioritised.

The evidence of outcomes related to a reduction in psychological distress is building. To strengthen our evidence base, the Government is going further than the Independent Sentencing Review recommendation by committing to extending and expanding the existing MMPSA feasibility pilot beyond the South-West region, to two additional regions, the North East and the North West, as the first steps towards a national roll-out. We are continuing to work closely with our partners across health and justice agencies to inform our plans for implementation throughout the Autumn.

Alongside the expansion of the pilot, we are working closely with experts to ensure all future decisions are based on strong evidence which prioritises public safety, including through our collaboration with Nottingham Trent University to conduct a Randomised Controlled Trial to understand the effectiveness of SSRIs in managing problematic sexual behaviours.

We are also conducting international research to inform our approach to MMPSA. This has included hosting an expert roundtable with international representation from Sweden and Germany, and targeted engagement with countries who use this medication, as recommended in the Review. A summary of the evidence available will be deposited in the House Library.

As the evidence builds, it is right we consider ways we can increase the use of MMPSA and we will continue to explore whether we might mandate this treatment in future.




Lord Keen of Elie mentioned

Parliamentary Debates
Renters’ Rights Bill
124 speeches (26,282 words)
Tuesday 15th July 2025 - Lords Chamber
Ministry of Housing, Communities and Local Government
Mentions:
1: Baroness Taylor of Stevenage (Lab - Life peer) My Lords, I thank the noble and learned Lord, Lord Keen of Elie, the noble Lord, Lord Cromwell, and my - Link to Speech
2: Baroness Taylor of Stevenage (Lab - Life peer) My Lords, I thank the noble and learned Lord, Lord Keen of Elie, the noble Lord, Lord Cromwell, and the - Link to Speech
3: None So, for the reasons I have set out, I ask kindly that the noble and learned Lord, Lord Keen of Elie, - Link to Speech
4: Baroness Taylor of Stevenage (Lab - Life peer) My Lords, I thank the noble Baroness, Lady Thornhill, and the noble and learned Lord, Lord Keen of Elie - Link to Speech



Written Answers
Prisons: Ministers of Religion
Asked by: Lord Godson (Conservative - Life peer)
Wednesday 10th September 2025

Question to the Ministry of Justice:

To ask His Majesty's Government, further to the Written Answer by Lord Keen of Elie on 4 July 2019 (HL16560), what is the number of prison chaplains for each recognised faith or belief.

Answered by Lord Timpson - Minister of State (Ministry of Justice)

The statutory duties of a prison chaplain are set out in the Prison Act 1952.

We recognise and respect the right of prisoners to register and practice their faith or belief while in custody. Chaplaincy plays a critical and unique role in the work of prisons and the life of prisoners. It not only provides advice on faith/belief matters, but also offers pastoral care, in support of HM Prison and Probation Service’s commitment to decency, safety and rehabilitation. Chaplains may work on an employed basis (either full-time or part-time), or be engaged on a contracted, sessional or voluntary basis.

The number of prison chaplains in prisons in England and Wales by faith or belief (as of 2 September 2025) is set out in the following table:

Faith/Belief

Number of Chaplains

Baháʼí

3

Buddhist

62

Christian

584

Christan Science

7

Church of Jesus Christ Latter-Day Saints

21

Hindu

22

Humanist and Non-Religious

13

Jehovah Witness

137

Jewish

35

Muslim

263

Pagan

26

Quaker

33

Rastafarian

13

Salvation Army

3

Seventh Day Adventist

3

Sikh

36

Spiritualist

5

Total

1,266

Data sources and quality:

The figures in the table have been drawn from administrative IT systems which, as with any large-scale recording system, are subject to possible errors with data entry and processing.



Parliamentary Research
Renters' Rights Bill 2024-25: Consideration of Lords amendments - CBP-10325
Sep. 02 2025

Found: Burden of proof for rental discrimination and rental bidding Lord Keen of Elie (Con) tabled amendment



Bill Documents
Sep. 02 2025
Renters’ Rights Bill 2024-25: Consideration of Lords amendments
Renters' Rights Bill 2024-26
Briefing papers

Found: Burden of proof for rental discrimination and rental bidding Lord Keen of Elie (Con) tabled amendment

Aug. 29 2025
Bill 296 EN 2024-25
Renters' Rights Bill 2024-26
Explanatory Notes

Found: Lords Amendments 26 and 27 were tabled by Lord Keen of Elie, and were opposed by the government. 14

Jul. 11 2025
HL Bill 103-III Third marshalled list for Report
Renters' Rights Bill 2024-26
Amendment Paper

Found: LORD KEEN OF ELIE THE EARL OF KINNOULL BARONESS SCOTT OF BYBROOK 87_ Clause 41, page 58, line 4, leave